Chad Glisch

3PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 07, 2022
Administration of Immune Checkpoint Inhibitors Near the End of Life.

Matthew D Bloom, Haneen Saker, Chad Glisch

|Jul 23, 2021
Immunotherapy in Patients With Poor Performance Status: The Jury Is Still Out on This Special Population.

Ali Raza Khaki, Chad Glisch, Laura A Petrillo

|Jul 17, 2019
Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital.

Chad Glisch, Yuya Hagiwara, Stephanie Gilbertson-White

Pageof 1